Neurofibromatosis, type 2 (NF2) is a rare genetic disorder that affects the nervous system. It is characterized by the growth of noncancerous tumors on the nerves that transmit sound and balance signals from the inner ear to the brain. These tumors, known as vestibular schwannomas or acoustic neuromas, can cause hearing loss, ringing in the ears, and problems with balance.
NF2 is caused by mutations in the NF2 gene, which plays a crucial role in regulating the growth of cells. These mutations lead to the uncontrolled growth of Schwann cells, which are responsible for the formation of the protective covering around nerve cells. As a result, tumors develop on the nerves throughout the body, particularly in the brain and spinal cord.
Symptoms of NF2 usually start in late adolescence or early adulthood. The most common signs include hearing loss, ringing in the ears (tinnitus), and problems with balance. Other symptoms may include facial weakness or numbness, difficulty swallowing, and vision problems. The severity of symptoms can vary widely among affected individuals.
It's important for individuals with NF2 to work closely with a team of healthcare professionals, including neurologists, geneticists, and audiologists, to develop an individualized treatment and management plan. Ongoing monitoring and regular follow-up appointments are crucial to track the progression of the condition and adjust the treatment as needed.
While NF2 can significantly impact the quality of life for those affected, advancements in medical research and supportive care continue to provide hope for improved management and potential future treatments.
Neurofibromatosis, type 2 (NF2) is a rare genetic disorder that affects the nervous system. It is characterized by the growth of non-cancerous tumors on the nerves that transmit sound and balance information from the inner ear to the brain. While there is no cure for NF2, several treatment options are available to manage the symptoms ...
To see full information about treatment please Sign up or Log in